Skip navigation
The FDA is warning that GLP-1 drugs like Ozempic and Zepbound can decrease blood flow to the optic…
0:00 / 0:20

The FDA is warning that GLP-1 drugs like Ozempic and Zepbound can decrease blood flow to the optic…

CBS Evening News with Tony Dokoupil

@CBSEveningNews475K followers

Visit on X
99 likesDownloadOriginal post

22,591 views

The FDA is warning that GLP-1 drugs like Ozempic and Zepbound can decrease blood flow to the optic nerve, increasing the risk of vision loss.

4 Comments

Comments from the original post on X (Twitter)

  • swag dad's profile picture

    @nohohomi

    What about Reta?

  • Island Progressive's profile picture

    @ssinp

    @CBSNews It would be interesting to know the stats. Ozempic is widely used to treat type II diabetes, and blindness is already a significant risk factor with diabetes. More research is definitely needed.

  • daniel ramirez gañan's profile picture

    @danielramirezg3

    Permanent vision damage with zero available treatments is a terrifying side effect. The absolute risk stays super low at roughly six cases per 100k people, but anyone getting sudden blurriness on these meds needs to hit up a doctor immediately.

  • Janis Kay Urban's profile picture

    @JanUrban12

    Up the Fees that Drug Makers and Medical Devices have to pay. Fund Independent Researchers. Mandate Unbiased Clinical Trials for 3 - 5 years. Fix ALL the Obsolete Loopholes in the 510(k) Regulatory Submission Policy. #Healthcare 4 #Wealthcare is #Sickcare #1stDoNoHarm